Berkshire Biomedical is developing the COPA™ system, a medication dispensing system designed to combine security, compliance support, remote monitoring, and data analytics with accurate oral liquid dispensing. The system aims to enhance personalized medication delivery and adherence through dual biometric identification technology.

Berkshire Biomedical

Berkshire Biomedical Corporation | 242 followers on LinkedIn. Developing Drug dispensing Technology to Accurately and Precisely Deliver Oral Liquid Drugs to Only the Intended Users | Berkshire Biomedical Corporation is a privately held medical device company.   Berkshire is pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems, to provide precise and accurate personalized medication delivery to only the Authenticated Intended User (AIU™).

The Company’s lead product under development, the Computerized Oral Prescription Administration System (COPA™), is a hand-held, automated, personalized oral liquid dispensing system designed and intended to deliver controlled and non-controlled liquid oral medications to only the Authenticated Intended User upon confirmation of dual biometric identifications (fingerprint and dentition).

CEO of The Point Group

Susan Owen

Berkshire Biomedical Corporation

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 6, 2024 2:52 PM	2a3c8000
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 6, 2024 2:52 PM	90449fd9
crunchbase trigger	general	Nov 6, 2024 2:52 PM	72f9489a
crunchbase profile	general
li profile	general	Nov 6, 2024 2:52 PM	9b4f087b
translate crunchbase fundingrounds	general
peers	general	Nov 6, 2024 2:52 PM	73e790f7
news basic	general	Nov 6, 2024 2:52 PM	4f93117e
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BERK

COM:BERKSHIREBIOMEDICAL

Berkshire Biomedical